Patents
Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780)
03/2013
03/27/2013CN102992942A Organic compound and organic light emitting device having the same
03/27/2013CN102988356A Medicine composition with carbazole alkaloid in clausena plants as antineoplastic activity ingredient and preparation method and application thereof
03/27/2013CN102382034B Synthetic method of N-amino-3-azabicyclo[3,3,0]octane hydrochloride
03/27/2013CN102229557B Semihydrate crystal of silodosin, preparation method thereof and medicinal composition containing semihydrate crystal
03/27/2013CN101659865B Gathering induced luminescence material containing triphenyl thylene structure, synthesis method and application thereof
03/27/2013CN101541749B Tetrahydrocyclopenta[b] indole compounds as androgen receptor modulators
03/27/2013CN101448785B Novel dipeptidyl peptidase iv inhibitors and processes for preparation and pharmaceutical compositions thereof containing the same
03/27/2013CN101321727B 肟酯光敏引发剂 Oxime ester photoinitiator
03/27/2013CN101305041B Photolatent systems
03/26/2013US8404863 Tetrahydroindoles having sphingosine-1-phosphate receptor activity
03/26/2013US8404740 Spirocyclic cyclohexane compounds
03/26/2013US8404689 Heterocyclic amide compounds useful as kinase inhibitors
03/26/2013US8404436 Methods of identifying modulators of GPR17
03/26/2013CA2724151C Novel derivatives of azabicyclo[3.2.0]hept-3-yl, their preparation process and the pharmaceutical compounds that contain them
03/21/2013WO2013040526A1 Antimicrobial compounds
03/21/2013WO2013039187A1 Guanidinobenzoic acid compound
03/21/2013WO2013037960A1 Ep1 receptor ligands
03/21/2013US20130072692 Pharmaceutically acceptable salts of thymodepressin and preocesses for their manufacture.
03/21/2013US20130072539 Anti-Cancer Tamoxifen-Melatonin Hybrid Ligand
03/21/2013US20130072519 2-phenyl benzoylamides
03/21/2013US20130072491 Prophylactic or therapeutic agent for diabetes or obesity
03/21/2013US20130072456 Bicyclic tetrahydropyrrole compounds
03/21/2013US20130071439 Methods and compositions for treating biofilms
03/21/2013US20130071370 Inhibitors of micro-rnas for use for preventing and/or attenuating skin ageing and/or for hydrating skin
03/21/2013CA2848786A1 Ep1 receptor ligands
03/21/2013CA2848561A1 Guanidinobenzoic acid compound
03/20/2013EP2570409A1 Aralkyl diamine derivatives and uses thereof as antidepressant
03/20/2013EP2570125A1 Ep1 receptor ligands
03/20/2013EP2569283A1 Process for preparing substituted 1,3-dihydro-2h-indol-2-ones
03/20/2013EP2569282A2 Method for separating off tryptophan
03/20/2013EP2569281A1 Novel methods for the preparation of p2x7r antagonists
03/20/2013EP2569263A1 A thionation process and a thionating agent
03/20/2013CN102985406A Process for preparing substituted 1,3-dihydro-2h-indol-2-ones
03/20/2013CN102985400A Process for producing optically active 3-substituted-3-formyl-2-hydroxypropanoic acid compound
03/20/2013CN102977630A Dispersing agent for organic pigment and use thereof
03/20/2013CN102977344A Conjugated polyelectrolyte photoelectric material and applications thereof in polymer light-emitting diodes
03/20/2013CN102977343A Organic semiconductor material containing amphiprotic side chains and application thereof to OLED (organic light emitting diode) devices
03/20/2013CN102977342A Conjugate polyelectrolyte photoelectric material based on poly-carbazole and application of conjugate polyelectrolyte photoelectric material based on poly-carbazole
03/20/2013CN102977032A Heterocyclic bridged biphenyls and their use in OLEDs
03/20/2013CN102977002A Preparation method of tryptophan and zinc complex as feed additive
03/20/2013CN102977001A Preparation method of tryptophan and cobalt complex as feed additive
03/20/2013CN102977000A Synthetic method of 3-methoxy-7-nitroindoline
03/20/2013CN102357093B Medicinal composition of methanesulfonic acid arbidol oral solid preparation
03/19/2013US8399880 Heteroarylamine compound and organic light-emitting device including the same
03/19/2013US8399684 Sulfonamide-based organocatalysts and method for their use
03/19/2013US8399503 Spirocyclic azaindole derivatives
03/19/2013US8399477 (Aza)indole derivative substituted in position 5, pharmaceutical composition comprising it, intermediate compounds and preparation process therefor
03/14/2013WO2013013113A3 Histone deacetylase 6 selective inhibitors for the treatment of bone disease
03/14/2013WO2012131710A3 Novel process for the synthesis of indoline derivatives
03/14/2013US20130065934 Fatty acid cox inhibitor derivatives and their uses
03/14/2013US20130065877 Substituted phenyl cycloalkyl pyrrolidine (piperidine) spirolactams and amides, preparation and therapeutic use thereof
03/14/2013US20130065863 Nitroxyl (hno) releasing compounds and uses thereof in treating diseases
03/13/2013EP2567698A1 GPR 17 agonists and screening assay
03/13/2013EP2566847A1 Novel immunomodulator and anti inflammatory compounds
03/13/2013CN1953967B Purification of progesterone receptor modulators
03/13/2013CN1938244B Fluoridation method
03/13/2013CN102971291A Novel amide derivative and use thereof as medicine
03/13/2013CN102971290A Cationic 6-aminoindolines, dyeing compositions containing them, processes and uses thereof
03/13/2013CN102964291A Organic compound, light-emitting element, light-emitting device, electronic device, and lighting device
03/13/2013CN102964290A Organic electroluminescence material containing dihydro pentacene and preparation method thereof
03/13/2013CN102964289A Method for preparing polycyclic aromatic compounds by D-A (Diels-Alder) reaction
03/13/2013CN102964288A Preparation method of feed additive tryptophan ferrous complex
03/13/2013CN102964287A New synthesis method of 3-(4-chlorobutyl)-5-cyanoindole
03/13/2013CN102146090B Luminescent material prepared from dianthracene compounds substituted by aromatic rings
03/13/2013CN102143989B Soluble terminally modified imide oligomer using 2-phenyl-4,4'-diaminodiphenyl ether, varnish, cured product thereof, imide prepreg thereof, and fiber-reinforced laminate having excellent heat resistance
03/13/2013CN101633636B Peptidomimetic protease inhibitors
03/12/2013US8394971 Indole derivatives as selective androgen receptor modulators (SARMS)
03/12/2013US8394970 Process for manufacturing a glutamic acid derivative and a pyroglutamic acid derivative and a novel intermediate in the manufacture thereof
03/12/2013US8394967 Antioxidant inflammation modulators: C-17 homologated oleanolic acid derivatives
03/12/2013US8394843 Substituted isoindoles as glucokinase activators
03/12/2013US8394510 Aromatic amine derivative and organic electroluminescence device using the same
03/12/2013CA2637933C Indole sulfonamide modulators of progesterone receptors
03/12/2013CA2562843C Process for the preparation of perindopril
03/12/2013CA2558051C Palladium catalyzed indolization of 2-bromo or chloroanilines
03/07/2013WO2013032960A2 Vitamin d receptor - coregulator inhibitors
03/07/2013WO2013032304A2 Organic electronic device and method for manufacturing same
03/07/2013WO2013032303A2 Organic electronic device
03/07/2013WO2013032278A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same
03/07/2013WO2013032035A1 Process for producing n-(hetero)arylazoles
03/07/2013WO2013031731A1 Organic electroluminescent device
03/07/2013WO2013031520A1 Organic electroluminescence element
03/07/2013WO2013029338A1 Novel compounds
03/07/2013WO2011153423A3 Processes and intermediates
03/07/2013US20130060048 Crystalline d-isoglutamyl-d-tryptophan and the mono ammonium slat of d-isoglutamyl-d-tryptophan
03/07/2013US20130060047 Novel methods for the preparation of p2x7r antagonists
03/07/2013US20130060046 Trimethine cyanine and its use
03/07/2013US20130059899 Methods of identifying modulators of gpr17
03/07/2013US20130059879 Small Molecule Inhibitors of PFKFB3 and Glycolytic Flux and Their Methods of Use as Anti-Cancer Therapeutics
03/07/2013US20130059874 Substituted n-phenyl spirolactam bipyrrolidines, preparation and therapeutic use thereof
03/07/2013US20130059853 Biaryl phosphodiesterase inhibitors
03/07/2013US20130059852 Compounds for treating disease, for administering, and for pharmaceutical compositions
03/07/2013US20130059791 Crystalline d-isoglutamyl-d-tryptophan and the mono ammonium slat of d-isoglutamyl-d-tryptophan
03/07/2013US20130056722 Novel organic compound
03/07/2013DE10213051B4 Substituierte 4-Aminocyclohexanole Substituted 4-aminocyclohexanols
03/07/2013CA2847119A1 Process for producing n-(hetero)arylazoles
03/06/2013EP2563761A1 Activators of human pyruvate kinase
03/06/2013CN1826344B (1S, 5S)-3-(5, 6-dichloro-3-pyridinyl)-3, 6-diazabicyclo[3.2.0]heptane is an effective analgesic agent
03/06/2013CN102958915A Compound having carbazole ring structure, and organic electroluminescent device
03/06/2013CN102958914A 1-phenyl-substituted heterocyclyl derivatives and their use as prostaglandin D2 receptor modulators
03/06/2013CN102958906A Novel organic electroluminescent compounds and organic electroluminescent device using the same
1 ... 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 ... 458